Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration

Purpose: Combined modality therapy with multiagent chemotherapy and radiation therapy is a standard treatment option for aggressive mediastinal non-Hodgkin lymphomas (AMNHLs); however, concerns regarding acute and late radiation toxicities have fueled an effort to use systemic therapy alone. The use...

Full description

Bibliographic Details
Main Authors: Jonathan A. Baron, MD, Christopher M. Wright, MD, Russell Maxwell, MD, Michele M. Kim, PhD, Fantine Giap, MD, Raymond B. Mailhot Vega, MD, MPH, Bradford S. Hoppe, MD, MPH, Michael J. LaRiviere, MD, Amit Maity, MD, PhD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422001968